A. Furby

1.3k total citations
20 papers, 361 citations indexed

About

A. Furby is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, A. Furby has authored 20 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 6 papers in Cellular and Molecular Neuroscience and 4 papers in Molecular Biology. Recurrent topics in A. Furby's work include Peripheral Neuropathies and Disorders (3 papers), Hereditary Neurological Disorders (3 papers) and Genetic Neurodegenerative Diseases (3 papers). A. Furby is often cited by papers focused on Peripheral Neuropathies and Disorders (3 papers), Hereditary Neurological Disorders (3 papers) and Genetic Neurodegenerative Diseases (3 papers). A. Furby collaborates with scholars based in France, Belgium and French Guiana. A. Furby's co-authors include Katell Beauvais, Claire De Barace, F. Mounier‐Véhier, J. Jacquesson, J.D. Guieu, J.L. Bourriez, Elisabeth Tournier‐Lasserve, Guillaume Bassez, Véronique Sebille and Philippe Latour and has published in prestigious journals such as The Journal of Physiology, Journal of Neurology Neurosurgery & Psychiatry and Neurobiology of Aging.

In The Last Decade

A. Furby

20 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Furby France 10 128 106 76 50 49 20 361
Sevinç Aktan Türkiye 10 151 1.2× 80 0.8× 75 1.0× 88 1.8× 76 1.6× 17 450
Michael Sabolek Germany 12 145 1.1× 104 1.0× 122 1.6× 16 0.3× 58 1.2× 20 442
Kayıhan Uluç Türkiye 12 155 1.2× 61 0.6× 56 0.7× 28 0.6× 19 0.4× 49 406
Kevin E. Crutchfield United States 8 154 1.2× 111 1.0× 33 0.4× 32 0.6× 19 0.4× 16 465
Shinsaku Nishio Japan 13 147 1.1× 161 1.5× 110 1.4× 48 1.0× 33 0.7× 20 476
B. A. Van Ketel Netherlands 5 134 1.0× 45 0.4× 60 0.8× 93 1.9× 32 0.7× 7 417
Kazuo Isozumi Japan 12 168 1.3× 66 0.6× 80 1.1× 30 0.6× 7 0.1× 38 403
Ashwin Kumaria United Kingdom 10 151 1.2× 85 0.8× 71 0.9× 73 1.5× 30 0.6× 42 375
A. Gardiner United Kingdom 6 89 0.7× 71 0.7× 83 1.1× 26 0.5× 14 0.3× 9 348
Ichiro Kamei Japan 13 216 1.7× 77 0.7× 150 2.0× 44 0.9× 21 0.4× 47 498

Countries citing papers authored by A. Furby

Since Specialization
Citations

This map shows the geographic impact of A. Furby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Furby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Furby more than expected).

Fields of papers citing papers by A. Furby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Furby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Furby. The network helps show where A. Furby may publish in the future.

Co-authorship network of co-authors of A. Furby

This figure shows the co-authorship network connecting the top 25 collaborators of A. Furby. A scholar is included among the top collaborators of A. Furby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Furby. A. Furby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Papadopoulos, Constantinos, Barbara Perniconi, Nadjib Taouagh, et al.. (2016). Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme®) in 12 patients with advanced late-onset Pompe disease. Neuromuscular Disorders. 26. S109–S110. 1 indexed citations
2.
Furby, A., Savine Vicart, Jean‐Philippe Camdessanché, et al.. (2014). Heterozygous CLCN1 mutations can modulate phenotype in sodium channel myotonia. Neuromuscular Disorders. 24(11). 953–959. 28 indexed citations
3.
Féasson, Léonard, A. Furby, Pascal Laforêt, et al.. (2013). PNPLA2 mutation: A paediatric case with early onset but indolent course. Neuromuscular Disorders. 23(12). 986–991. 16 indexed citations
4.
Beauvais, Katell, et al.. (2011). Prognostic value of EEG in very premature newborns. Archives of Disease in Childhood Fetal & Neonatal. 97(2). F106–F109. 47 indexed citations
5.
Furby, A., et al.. (2009). Rural environment and risk factors of amyotrophic lateral sclerosis: a case–control study. Journal of Neurology. 257(5). 792–798. 36 indexed citations
6.
Furby, A., Anthony Béhin, Katell Beauvais, et al.. (2009). Late-onset cervicoscapular muscle atrophy and weakness after radiotherapy for Hodgkin disease: a case series. Journal of Neurology Neurosurgery & Psychiatry. 81(1). 101–104. 51 indexed citations
7.
Sèze, J. de, et al.. (2006). Syndrome de Guillain-Barré sévère et grossesse : deux cas d’amélioration rapide en post-partum. Revue Neurologique. 162(3). 358–362. 9 indexed citations
8.
Sèze, J. de, et al.. (2006). Syndrome de Guillain-Barré sévère et grossesse : deux cas d’amélioration rapide en post-partum: Hypotheèses étiopathogéniques et revue de la littérature. Revue Neurologique. 162(3). 358–362. 3 indexed citations
10.
Bendahhou, Saı̈d, Emmanuel Fournier, Damien Sternberg, et al.. (2005). In vivo and in vitro functional characterization of Andersen's syndrome mutations. The Journal of Physiology. 565(3). 731–741. 24 indexed citations
11.
Beauvais, Katell, Florence Riant, Claire De Barace, et al.. (2004). New CACNA1A Gene Mutation in a Case of Familial Hemiplegic Migraine with Status epilepticus. European Neurology. 52(1). 58–61. 38 indexed citations
12.
Furby, A., et al.. (2001). [Hepatitis C with cryoglobulinemia associated with Guillain-Barre syndrome].. PubMed. 30(15). 739–739. 1 indexed citations
13.
Furby, A., et al.. (2000). [Polyradiculoneuropathy in an adult with primitive hyperoxaluria].. PubMed. 156(1). 62–4. 2 indexed citations
15.
Furby, A., et al.. (1993). Effects of chronic electrostimulation on rat soleus skinned fibers during hindlimb suspension. Muscle & Nerve. 16(7). 720–726. 7 indexed citations
16.
Furby, A., J.L. Bourriez, J. Jacquesson, F. Mounier‐Véhier, & J.D. Guieu. (1992). Motor evoked potentials to magnetic stimulation: technical considerations and normative data from 50 subjects. Journal of Neurology. 239(3). 152–156. 44 indexed citations
17.
Rondepierre, Ph., A. Furby, Olivier Godefroy, et al.. (1992). [Mixed pre- and postsynaptic neuromuscular block].. PubMed. 148(3). 193–9. 1 indexed citations
18.
Leys, Didier, et al.. (1991). Early hypopituitarism following cavernous sinus thrombosis: Total recovery within 1 year. Clinical Neurology and Neurosurgery. 93(3). 249–252. 9 indexed citations
19.
Furby, A., et al.. (1990). [Prolonged remission in subacute sclerosing panencephalitis: 2 cases].. PubMed. 146(3). 191–5. 5 indexed citations
20.
Furby, A., et al.. (1990). Are alpha-1-antichymotrypsin and inter-alpha-trypsin inhibitor peripheral markers of Alzheimer's disease?. Neurobiology of Aging. 11(3). 338–339. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026